Gene: PLEKHA1
Official Full Name: pleckstrin homology domain containing A1provided by HGNC
Gene Summary: This gene encodes a pleckstrin homology domain-containing adapter protein. The encoded protein is localized to the plasma membrane where it specifically binds phosphatidylinositol 3,4-bisphosphate. This protein may be involved in the formation of signaling complexes in the plasma membrane. Polymorphisms in this gene are associated with age-related macular degeneration. Alternate splicing results in multiple transcript variants. A pseudogene of this gene is found on chromosome 5.[provided by RefSeq, Sep 2010]
Catalog Number | Product Name | Species | Gene | Passage ratio | Mycoplasma testing | Price |
---|---|---|---|---|---|---|
KO15087 | PLEKHA1 Knockout cell line (HeLa) | Human | PLEKHA1 | 1:3~1:6 | Negative | Online Inquiry |
KO15088 | PLEKHA1 Knockout cell line (HCT 116) | Human | PLEKHA1 | 1:2~1:4 | Negative | Online Inquiry |
KO15089 | PLEKHA1 Knockout cell line (HEK293) | Human | PLEKHA1 | 1:3~1:6 | Negative | Online Inquiry |
KO15090 | PLEKHA1 Knockout cell line (A549) | Human | PLEKHA1 | 1:3~1:4 | Negative | Online Inquiry |
PLEKHA1 Gene Knockout Cell Lines are genetically engineered cell lines that have undergone the precise deletion of the PLEKHA1 gene, which is implicated in various cellular processes, including cytoskeletal organization and intracellular signaling. This product allows researchers to investigate the specific roles of PLEKHA1 in diverse biological contexts by providing a controlled environment where the gene's expression is effectively silenced.
The primary mechanism behind these knockout cell lines involves the utilization of CRISPR-Cas9 technology, which induces double-strand breaks in the target gene, thereby facilitating its deletion through the cell’s natural DNA repair pathways. By eliminating PLEKHA1 expression, researchers can elucidate its contributions to cellular behaviors, such as proliferation, apoptosis, and response to extracellular stimuli.
The scientific significance of PLEKHA1 Gene Knockout Cell Lines extends beyond basic research, with applications in cancer biology, neurobiology, and disease modeling. Understanding PLEKHA1's function can lead to insights into pathophysiological mechanisms and provide potential therapeutic targets for intervention in diseases characterized by dysregulated signaling.
Compared to traditional gene knockdown methods, such as RNA interference, these knockout cell lines offer permanent gene inactivation, which is crucial for studies that require long-term observations. Additionally, the specificity and efficiency of CRISPR technology minimize off-target effects, enhancing the reliability of experimental results.
For researchers and clinicians looking to probe the complexities of PLEKHA1-associated pathways, these knockout cell lines represent an invaluable tool. They facilitate a more profound understanding of cellular mechanisms, allowing for innovative discoveries that may translate into clinical applications.
Our company specializes in the development of high-quality, precise genetic tools, ensuring that our PLEKHA1 Gene Knockout Cell Lines are produced with the highest standards of scientific rigor. By harnessing advanced genomic techniques, we empower advancements in biological research that can lead to significant breakthroughs in medical science and therapeutics.
Please note that all services are for research use only. Not intended for any clinical use.
If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.
There is no product in your cart. |
CD Biosynsis is a leading customer-focused biotechnology company dedicated to providing high-quality products, comprehensive service packages, and tailored solutions to support and facilitate the applications of synthetic biology in a wide range of areas.